peripheral blood mononuclear leukocytes (PBMC) during the immune response to viral challenge as the cells are recruited to the respiratory tract. The current studies demonstrated differences in PBMC responses to the two viruses very early after exposure, including reduced fos protein and CD69 expression and IL-2 production by RSV-exposed T lymphocytes. Exposure to RSV resulted in reduced lymphocyte proliferation despite evidence of a virus-specific T lymphocyte frequency equivalent to that for influenza virus. Reduced RSV-induced proliferation was not due to apoptosis, which was itself reduced relative to that of influenza virus-exposed T lymphocytes. The data indicate that differential immune responses to RSV and influenza virus are determined early after exposure of human PBMC and support the concept that the anamnestic immune response that might prevent clinically evident reinfection is attenuated very soon after exposure to RSV. Thus, candidate RSV vaccines should be expected to reduce but not prevent clinical illness upon subsequent infection by RSV.
mistaken for illness caused by influenza A virus (IAV). 1, 3 RSV has been associated with over 11 000 deaths yearly in the USA, and older individuals are most likely to die as a result of the infection. 4 Both healthy elderly patients and high-risk adults can be infected, but severe disease in the elderly is related most closely to underlying medical conditions. 5 Symptomatic reinfection with RSV is common, and although repeat infections are associated with less morbidity and mortality than the initial infection, 6 the pathogenesis of reinfection is incompletely described. Although RSV does exhibit some strain variation, it has not been found to account for reinfection 7, 8 that can occur despite preexisting serologic and cellular evidence of sensitization and immunity to the challenging strain of RSV. 9 Longitudinal studies of RSV infections in children showed that children can be naturally reinfected with the same strain of virus 10 although subsequent disease severity is usually reduced, especially as the child ages. 11 A single RSV isolate has been shown to cause repeated experimental symptomatic infections in adult volunteers, 6 effectively eliminating strain variation as the singular determinant of reinfection. Such evidence suggests that RSV reduces human innate immune responses and/or anamnestic adaptive immune responses acutely but incompletely, allowing clinically evident re-infection. 12 In contrast to RSV, IAV induces adequate immune protection against clinical infection with homotypic strains. 13 Coordinated recruitment, clonal expansion, and activation of virus-specific effector T lymphocytes are critical to control, and recover from, a respiratory virus infection. Monocytes and monocytederived macrophages and lymphocytes migrate to the lungs in response to the respiratory virus challenge 14 on their mission to ensure defense and recovery, and thus are exposed to the virus. Even circulating leukocytes appear to be infected by RSV in vivo during initial but not subsequent natural infection. 15 Our in vitro studies use human peripheral blood-derived mononuclear cells (PBMC) obtained from adults who would have been naturally and recurrently exposed to RSV and IAV in vivo. 16, 17 Both RSV and IAV abortively infect both human monocytes-macrophages and lymphocytes. 15, 18, 19 Past studies showed that exposure of the PBMC to RSV or to IAV results in substantial differences in both innate immune responses, such as interferon production, 20, 21 and adaptive immune responses, such as T lymphocyte expression of late activation markers and cell proliferation measured by classical assays 7 days after exposure. 22, 23 Notably, RSV-exposed monocytes-macrophages supported mitogen-stimulated lymphocyte responses as well as did control monocytes-macrophages, whereas RSV-exposed lymphocytes did not respond whether supported by control or RSVexposed monocytes-macrophages. 24 Thus, RSV appeared to affect lymphocyte function specifically in proliferative responses. The current studies were undertaken to examine early events associated with PBMC exposure to RSV, compared with cells that were shamexposed or exposed to IAV, in order to identify alterations in lymphocyte function specifically that might result in attenuated or delayed defense against RSV, 1 possibly contributing to the risk of reinfection. for 2 min at room temperature, washed, and incubated with a 1:100 dilution of a rabbit polyclonal antibody specific for human Fos (Caltag).
Secondary staining was done with a 1:500 dilution of a goat anti-rabbit F(ab́)2 antibody conjugated to PE (Tago). frozen at −70°C until tested for soluble IL-2 levels using the human Th1/Th2 Cytokine Cytometric Bead Analysis (CBA) kit (BD Pharmingen, San Diego, CA), as described by the manufacturer.
| Analyses of lymphocyte proliferation and IL-2 production

| Enumeration of virus specific T cells
PBMC were resuspended and washed twice in PBS to remove virusspecific antibodies present in the human serum. Subsequently, PBMC were resuspended in RPMI supplemented with streptomycin (100 U/mL), penicillin (100 µg/mL), and glutamine (2 mM). They were then shamexposed or exposed to uv-inactivated RSV or IAV at 37°C for 1 h at an MOI of 3. After 1 h incubation at 37°C, the PBMC were spun down and re-suspended in RPMI supplemented with 10% fetal calf serum (FCS) at 37°C. Subsequently, Golgistop (Pharmingen) was added and left for a subsequent 5 h, at 37°C, as described previously. 28 The cells were then washed and stained with PerCP- After two washing steps with permeabilization buffer, the cells were fixed with Cytofix, and the number of cytokine-positive cells was determined using flow cytometry (FACS scan, Becton-Dickinson).
The percentage of cytokine-positive cells within the CD3 + , CD4+, or CD8+ T cell fraction was calculated for each exposure to virus.
| Analyses of cell apoptosis
Apoptosis was determined by quantitation of DNA strand breaks using the TUNEL Assay (In Situ Cell Death Kit, Boehringer Mannheim, Indianapolis IN). 25 Cell phenotype was established by cell surface labeling with monoclonal antibodies prior to the TUNEL reaction. After staining, cells were fixed in 2% PAF and permeabilized for 10 min using 0.6% n-octyl glucopyranoside (Sigma Chemical Co.). The TUNEL reaction was carried out as described in the manufacturer's instructions.
| Statistical analyses
Results are expressed as mean ± SD for the stated number of experiments. The statistical significance of differences in the means was calculated using the Student's t test performed by EXCEL software (Microsoft, Inc., Redmond, WA), comparing RSV-exposed cells to IAV-exposed cells or RSV-exposed cells to sham-exposed cells. Mean differences in the values were considered significant when P was less than 0.05.
3 | RESULTS
| Virus-induced T lymphocyte activation
In lymphocytes, Fos is an important immediate-early transcription factor involved in the regulation of expression of many effector molecules involved in lymphocyte proliferation and effector function.
Expression of Fos was examined using flow cytometry analysis 
| Virus-exposed T lymphocyte proliferation and IL-2 production
To analyze proliferation in T cells exposed to IAV and RSV, we used CFSE which is serially diluted with cell division, allowing determination of both the extent and the kinetics of cellular proliferation. 27 PBMC were sham-exposed or exposed to the viruses and CD3 + T cells were subsequently analyzed for CFSE content on days 1, 3, and 
| Virus-induced T lymphocyte apoptosis
Analyses of apoptosis showed that, whereas exposure to infectious influenza virus induced apoptosis as expected, 25 exposure of the PBMC to RSV induced far less CD3 + T cell apoptosis than did IAV ( Figure 5 ). Thus, reduced lymphocyte proliferation in response to RSV was not due to increased apoptosis relative to IAV. Exposure to inactivated IAV or RSV in the same experiments did not induce apoptosis relative to sham-exposed PBMC in the 48 h after exposure (1.75 ± 0.54, 1.09 ± 0.37, and 1.29 ± 0.31, mean percent ± SD, respectively).
| Enumeration of RSV-and IAV-specific T lymphocytes
In order to assess virus-specific T cells present at the time of exposure to RSV and IAV, we measured the relative percentages of virus-specific T lymphocytes in PBMC of five healthy donors sham-exposed or exposed to uv-inactivated RSV or IAV, and compared the production of IFN-γ by the lymphocytes as early as 6 h after exposure.
There were similar percentages of lymphocytes producing IFN-γ early (up to 6 h) after exposure to uv-inactivated IAV and RSV. This was true for IAV-and RSV-exposed total CD3 + cells (0.24 ± 0.11 and 0.26 ± 0.09, mean percent ± SD, respectively) as well as CD4+ 
| DISCUSSION
The data from the current studies support the concept that recurrent RSV infection may be related at least in part to early RSV effects on lymphocyte function 1 rather than due only to inadequate generation or persistence of immunity after previous infections as suggested by some animal models. 29 Virus-induced early responses of human lymphocytes measured after exposure to RSV were consistently reduced or delayed compared with determinations of cell function in response to exposure to IAV. Early effects on an anamnestic immune response such as observed in these studies, especially the likely reduced clonal expansion of RSV-specific lymphocytes, might allow RSV reinfection to progress to clinically evident illness.
Alterations in the magnitude and kinetics of immune responsiveness to RSV could contribute to the limited adaptive immunity to the virus that has been reported in both human and experimental mouse models of RSV infection 30 and explain at least in part clinical RSV reinfection. 29 Both antibody and CD8+ T cell responses are established during a primary response to RSV but ex vivo analyses of PBMC from infected children suggest that responses to the virus may not be boosted by episodes of reinfection. 30 RSV-specific memory T lymphocytes present in mice as a result of primary virus infection or peptide vaccination were present in the lung at the time of RSV reinfection but responding at low frequency. 29 Thus, although RSV quadrants of the divided regions of CFSE content, from most extensively divided to least divided (left to right) as illustrated in Figure 3B . Results are shown as mean percent of total CD3 + cells based on seven experiments using cells from different donors with measurements at 7 days after exposure. For each sample, data from 10 000 cells were collected. IAV, influenza A virus; RSV, respiratory syncytial virus.
FIGURE 4 IL-2 concentrations in supernatant fluids of IAV-and RSV-exposed PBMC. PBMC were sham-exposed, exposed to IAV or RSV at an MOI of one for 1 h. Supernatants were harvested at 24 h and IL-2 levels were determined for each group by cytometric bead array analysis. For each assay, 2 × 10 6 cells were used. Mean results ± SD are shown for four experiments using cells from different donors RSV. 23 Fos and Jun transcription factors also regulate the expression of CD69, 33 an indicator of T lymphocytes that have been activated through the T cell receptor. 34 Few T lymphocytes exposed to RSV expressed CD69 on their cell surface in comparison with those exposed to IAV.
Earlier studies using tritiated thymidine incorporation assays or cell cycle analyses suggested that there was minimal proliferation of virus-specific lymphocytes after exposure of PBMC to RSV. 22 The current studies used a CFSE proliferation assay that allowed both cumulative and kinetic measurements, and suggested that RSVexposed human PBMC do respond to the virus with a decreased, and possibly delayed, but not absent T lymphocyte proliferative response.
There was a degree of asymmetry in CFSE distribution with lymphocyte division, with recruitment of cells to the proliferative response, and the asymmetry and time lags of lymphocyte division as expected. 35 More T lymphocytes had completed more cell divisions by day 7 in the IAV-exposed PBMC than in the PBMC exposed to RSV.
Rather than being completely unresponsive to RSV, the T lymphocytes were proliferating, but at a decreased pace. It is quite clear, however, that a small percentage change in cell cycle rate in a population of cells that should be expanding exponentially can produce outcome differences of more than two orders of magnitude within a week's time, given the rate at which lymphocytes multiply. 36 The current studies did not establish the antigen-specific nature of the cells, and the responding activated T lymphocytes could include both virus-specific and bystander cells 37 although we have shown that the small percentage of lymphocytes responding early after exposure are virus-specific. 38 The lymphoproliferative response to viral challenge involves a rapid expansion of cells. Murine studies have shown a dramatically rapid and large increase in the number of restimulatable (memory) precursor CTL by 2-4 days post-immunization with influenza virus. 39 While the virus-specific response proceeds, bystander T cell activation in response to viral challenge, such as exhibited by expression of CD69, has been well documented. Such activation is TCR-independent and also occurs via cytokine stimulation in infections such as LCMV, HSV, HIV and SIV, dengue, and others, 40, 41 potentially leading to apoptosis of the cells. Human monocytesmacrophages produce an extensive pro-inflammatory and antiinflammatory repertoire of cytokines as well as cytokine inhibitors 42, 43 upon virus challenge. For example, they secrete both IL-1 and IL-1-inhibitors in response to both influenza virus and RSV, with the net biological response to influenza being pro-inflammatory and the net response to RSV being anti-inflammatory. 44 Our earlier studies 38 combined with the current data and the investigations by others that are cited above together suggest that the earliest activation/ proliferation response to influenza virus is exhibited by the small percent of virus-specific T cells, followed by the recruitment of bystander cells in response to the cytokines produced by monocytesmacrophages, evolving into a primarily virus-specific proliferative and effector response. Such a complex response overall is reduced or delayed after exposure to RSV.
Fewer proliferating T lymphocytes were observed in the RSVexposed PBMC than in the IAV population in spite of similar percentages of virus-specific precursor lymphocytes. Our earlier studies also showed RSV-specific lymphocytes in PBMC from adults, with robust proliferation in response to inactivated RSV but markedly reduced proliferation after exposure to infectious RSV. 23 In the current studies, the reduced proliferation of the RSV-exposed PBMC was shown not to be due to virus-induced apoptosis, which was itself reduced compared to that of the IAV-exposed cells. Prior studies showed that the percentage of cells that are IAV-infected is less than the percentage of apoptotic cells, suggesting that direct effects of cell infection by the virus cannot account fully for a high level of cell death. 25 Furthermore, for the IAV-exposed cells, apoptosis was unlikely to contribute to diminished cellular CSFE since apoptotic lymphocytes would be engulfed by monocytesmacrophages, 45 and not analyzed by the flow cytometric gates set for lymphocytes.
IAV and RSV infect similar percentages of human monocytesmacrophages and lymphocytes. 15 RSV infection of adult PBMC appears to be recognized as vigorously as IAV as measured by early biophysical changes in the small populations of lymphocytes that were in turn shown to be virus-specific by deletion and reconstitution experiments, 38 although the IAV-exposed cells proliferated and the RSV-exposed cells showed cell cycle arrest. 22 Our experiments that evaluated the frequency of virus-specific T cells used exposure to UV inactivated IAV and RSV for enumeration of virus-specific T cells. This method preserved antigenic sites while eliminating effects due to viral replication. The data showed that there were similar percentages of lymphocytes producing IFN-γ early after exposure to RSV and IAV.
Our results regarding percentages of IAV-and RSV-specific lymphocytes in adult peripheral blood are similar to those reported by others. 46, 47 In spite of a similar number of precursor cells, there was a decreased response in the RSV-exposed population compared to IAVexposed cells over time that correlated with the findings of a decreased IL2 production after infection, and decreased IL-2 production has been associated with a decreased proliferation of lymphocytes 48 as seen in our studies. 
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